medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Development of a core outcome set for IBD patients with stomas. J Crohns Colitis Kumar L, Hanly M, Fennessy A, O'Morain N, Martin S, Keogh A, Burns R, Kehoe A, Dames N, Kimman M, Sahnan K, Tozer P, Doherty G, TOAST-IBD Collaborators. PMID: 42951344 [PubMed - indexed for MEDLINE]
	Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Disease Strictures: The BEST-CD Randomized Trial. Clin Gastroenterol Hepatol Pal P, Pooja K, Naaz SM, Marri UK, Rebala P, Gupta R, Rao GV, Tandan M, Reddy DN. PMID: 42950934 [PubMed - as supplied by publisher]
	Prospective evaluation of an optimized low-dose CT enterography protocol for patients with Crohn's disease. Eur J Radiol Chen H, Tang B, Li J, Jin Y, Fu Q, Wu W, Zhang L. PMID: 42950525 [PubMed - as supplied by publisher]
	Sustained Efficacy and Safety of Mirikizumab Through 152 Weeks in Chinese Patients with Moderately to Severely Active Crohn's Disease: A Subpopulation Analysis of the VIVID-1 and VIVID-2 Phase 3 Trials. BioDrugs Gao X, Cao Q, Liu X, Chen B, Liu W, Tang W, Wang Y, Zhong J, Li Z, Wang X, Sun Y, Gupta P, Yu J, Xu J, Chen M. PMID: 42946942 [PubMed - as supplied by publisher]
	UK national analysis of colonoscopy quality in inflammatory bowel disease surveillance: a National Endoscopy Database (NED) cohort study. J Crohns Colitis Pohl K, Nigam GB, Kent A, East JE, Bhandari P, Feeney M, Dodds P, Tibbatts C, Dolwani S, Noble C, Hall P, Lee T, Beaton D, Rutter MD, Burr N, Din S. PMID: 42946452 [PubMed - indexed for MEDLINE]
	Microbiota-Associated Metabolites as Biomarkers and Therapeutic Opportunities in Inflammatory Bowel Disease. Nutrients Krysa K, Musz P, Ry, Serafin P, Wachowiak D, Jarmakiewicz-Czaja S. PMID: 42942943 [PubMed - indexed for MEDLINE]
	Dietary Polyphenols as Adjunctive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients Dong Y, Xu H, Zhang D, Ren X, Wu X, Zheng Z, Yu Q, Shen Y. PMID: 42942906 [PubMed - indexed for MEDLINE]
	A Mesalazine-Aloperine Co-Amorphous System for Simultaneous Dissolution Enhancement, Permeability Improvement, and Synergistic Anti-Ulcerative Colitis Activity: A Combined Pharmaceutics and Network Pharmacology Study. Pharmaceutics Su H, Guo N, Yuan S, Huang J, Wei N, Xu H, Liu Y. PMID: 42942819 [PubMed]
	Impact of Smoking on the Effectiveness of Advanced Therapies in Inflammatory Bowel Disease: Active Smoking Is Associated with Reduced Effectiveness of Anti-TNF Treatment. Medicina (Kaunas) Cinque S, Annunziata ML, Bianchi A, Bertoli P, Dell'Anna G, Messina M, Fanizza J, Sociale OR, Annese M, Annese V. PMID: 42942364 [PubMed - indexed for MEDLINE]
	Receptor-Side Neuroimmune Remodeling in IBD: Participant-Level Associations with Metabolite-Sensing Programs and Colorectal Neoplasia Context. Int J Mol Sci Hu H, Xu K, Yuan X, Lei Z, Lu Y. PMID: 42941949 [PubMed - indexed for MEDLINE]
	Propolis Flavonoids: Current Evidence in Animal Models and Future Promise for the Treatment of Ulcerative Colitis. Int J Mol Sci Hernández-Sánchez KM, Nieto-Yañez O, Rivera-Yañez CR, Pedroza-González A, Francisco-Cruz L, Hernández-Delgado CT, Molina-Gallardo AR, Hernández-Rosas NA, Ruiz-Hurtado PA, Barrera-Ortega CC, Rivera-Yañez N. PMID: 42941821 [PubMed - indexed for MEDLINE]
	The Impact of Multiple Biologic Failures on Surgical Outcomes: A Retrospective Cohort Study of Elective Subtotal Colectomy for Ulcerative Colitis. J Clin Med Rudnicki Y, Jeffery JR, Derakshani D, Mathis KL. PMID: 42941636 [PubMed]
	Gut Microbiota-Driven Neuroimmune Crosstalk in Ulcerative Colitis: From Mechanisms to Therapeutic Implications. Biomedicines Yu L, He L, Lu Y. PMID: 42940167 [PubMed]
	Prior Ustekinumab Exposure and Ulcerative Colitis Are Associated with Suboptimal Trough Levels in Patients Receiving Advanced-Line Vedolizumab or Ustekinumab for Inflammatory Bowel Disease: A Cross-Sectional Cohort Study. Biomedicines Nagypál P, Kovács K, Vásárhelyi B, Dezs, Miheller P, Iliás Á, Béres NJ, Balogh A, Prehoda B, Tóbi L, Szabó AJ, Cseh Á. PMID: 42940137 [PubMed]
	Novel Therapeutic Strategies for Active Crohn's Disease: Targeting Pathobionts and Host-Microbe Interactions. Antibiotics (Basel) Iaquinto G, Picariello E, Iaquinto S, Melina R, Sellitto C, Sellitto S, Cataldo G, Pastore R, Rotondi Aufiero V. PMID: 42938706 [PubMed]
	Nomogram-Based Outcome Prediction Models in Patients with Inflammatory Bowel Disease. Niger J Clin Pract Shao X, Yuan Z, Zhang H, Tang C, Wang W, Tang Y, Lin D. PMID: 42937375 [PubMed - indexed for MEDLINE]
	Prognostic Value of C-Reactive Protein for Intestinal Resection in Crohn's Disease Patients with Clostridioides difficile Infection: A Single-Center Retrospective Cohort Study. J Inflamm Res Zheng M, Pang X, Li L, Chen R, Tie Y, Zhang S. PMID: 42936764 [PubMed]
	The Efficacy and Safety of Etrasimod for the Induction and Maintenance of Remission in Moderate to Severe Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials. Cureus Riaz CZ, Raza M, Afraz I, Chaudhry ER, Aslam A, Anwaar A, Qureshi AJ, Jannat M, Basit AR, Ahmed MW, Qureshi MH. PMID: 42936731 [PubMed]
	Gut microbiota, microbial metabolites, and mucosal barrier dysfunction in benign anorectal disorders and ulcerative colitis: shared mechanisms, clinical links, and precision interventions. Front Med (Lausanne) Yuan H, Zhao M, Wang Y, Shen C, Liu D, Wang C, Liu J. PMID: 42936295 [PubMed]
	Nancy Histological Index and endoscopic activity, clinical activity, and disease extent in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr Sheikholeslami A, Vajihinejad M, Edalatkhah R, Soleimani N, Askari A, Eslami S. PMID: 42935116 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 59235

Seite 1 von 2962



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung